DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03744637 (ClinicalTrials.gov)	January 18, 2019	13/11/2018	A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance (MK-5475-002)	A Study to Assess the Effect of Single Doses of MK -5475 on Pulmonary Vascular Resistance in Patients With Moderate to Severe Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: MK-5475;Drug: Placebo	Merck Sharp & Dohme Corp.	NULL	Active, not recruiting	18 Years	70 Years	All	25	Phase 1	Moldova, Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03744637
(ClinicalTrials.gov)

January 18, 2019

13/11/2018

A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance (MK-5475-002)

A Study to Assess the Effect of Single Doses of MK -5475 on Pulmonary Vascular Resistance in Patients With Moderate to Severe Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Drug: MK-5475;Drug: Placebo

Merck Sharp & Dohme Corp.

NULL

Active, not recruiting

18 Years

70 Years

All

Phase 1

Moldova, Republic of